Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia

Conclusion: Our findings suggest that the risk variant at the DRD2 locus can be used as an indicator for patients ’ responses to antipsychotics without direct DRD2-blocking, thereby shortening the time needed for drug selection.Neuropsychobiology

https://www.karger.com/Article/FullText/519155

Source: Neuropsychobiology - September 28, 2021 Category: Psychiatry & Psychology Source Type: research